DSIP-Like Peptide Significantly Reduces Brain and Heart Damage Post-Ischemia

Ischemic events, such as stroke and myocardial infarction (heart attack), cause severe tissue damage due to lack of blood flow. Even when blood flow is restored (reperfusion), this process can paradoxically lead to further injury, known as ischemia-reperfusion injury. Current treatments often focus on restoring blood flow, but effective pharmacological interventions specifically targeting reperfusion injury to minimize subsequent tissue damage are still critically needed.

Administration of DSIP-Like KND Peptide during reperfusion significantly reduced infarct size in both brain and heart models. In C57Bl/6 mice, the 0.5 mg/kg dose led to a 42% reduction in brain infarct volume compared to vehicle control (p<0.01), while the 0.1 mg/kg dose showed a 28% reduction (p<0.05). In SD rats, the 0.5 mg/kg dose resulted in a 35% decrease in myocardial infarct size (p<0.05) relative to controls, with a 20% reduction observed at 0.1 mg/kg (p<0.05). The most significant finding was the consistent and substantial reduction in tissue damage across two different organ systems, demonstrating broad protective effects of the peptide when administered at the critical reperfusion phase. These protective effects were observed without significant changes in physiological parameters like blood pressure or heart rate, suggesting a direct tissue-protective mechanism.